Patents by Inventor Joel D. Pardee

Joel D. Pardee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090104171
    Abstract: A Metabolic Enhancement Therapy nutritional supplement for treating symptoms and conditions such as acute anxiety, hyperactivity, panic attacks, confusion, involuntary movements, sleep disorders, mood disorders, depression, anger, seizures, obsessive-compulsive behavior, unregulated fear, panic, neuronal disorders, autism, schizophrenia, attention deficit disorder (ADD), attention deficit hyperactive disorder (ADHD) and neuronally based immunologic disorders by administering to a mammal an effective amount of acetyl-L-carnitine, ?-lipoic acid, biotin, vitamin B1, L-glutamine, Vitamin B6, taurine, folinic acid, vitamin B12, trimethylglycine, and L-tryptophan.
    Type: Application
    Filed: March 11, 2008
    Publication date: April 23, 2009
    Inventors: Joel D. Pardee, Alexander V. Birk
  • Publication number: 20030022258
    Abstract: Compositions and methods are provided for actin regulatory proteins including human severin (H-severin) and H-30; and their uses including the preparation of polyclonal and monoclonal antibodies for use in diagnosing and staging the progression of metastatic tumors and other disorders of cellular growth regulation. Also provided are methods of screening to identify potential drug candidate molecules which modulate the activity of human severin or H-30 and methods of use of such compounds to accelerate wound healing, or to treat a metastasis or growth disorder.
    Type: Application
    Filed: March 25, 2002
    Publication date: January 30, 2003
    Applicant: Cornell Research Foundation, Inc.
    Inventor: Joel D. Pardee
  • Patent number: 6403766
    Abstract: Protein compositions and methods of use are provided for human Severin. The uses include the preparation of polyclonal and monoclonal antibodies for diagnosing and staging the progression of metastatic tumors and other disorders of cellular growth regulation. Also provided are methods of screening to identify potential drug candidate molecules which modulate the human Severin activity and methods of use of such compounds to accelerate wound healing, or to treat a metastasis or growth disorder.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: June 11, 2002
    Assignee: Cornell Research Foundation, Inc.
    Inventor: Joel D. Pardee